GLP-1 usage is on the rise, and researchers are looking for other health benefits associated with the drug, including its effects on bladder health. But as GLP-1s rise in popularity, so do nicknames ...

XReal has launched a new entry-level AR glasses model in Japan, the XReal 1S. It slots below the XReal One Pro announced earlier this year and is the first pair of consumer AR glasses to offer ...

Hims & Hers maintains its long-term Buy rating, despite recent stock volatility and slower subscriber growth. HIMS continues to expand its platform beyond GLP-1s, investing heavily in verticalization ...

Weight-loss drugs are coming for a new kind of customer. “You don’t need to be obese to start a GLP-1,” reads an ad from a telehealth startup, the words scrawled in icing on a cake. Another one ...

When Chevese Turner first discussed Ozempic with her doctor to treat her diabetes, she was both worried and relieved. Finally, “there was something effective that [was] going to address my diabetes,” ...

Morgan Williams will fill her Thanksgiving plate this year with green bean casserole, her favorite dish – only to not eat it all. That's because Williams' appetite is diminished and has changed ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

GLP-1 RAs, particularly semaglutide and tirzepatide, outperform older medications in achieving significant weight loss in adults with and without type 2 diabetes. Semaglutide and tirzepatide met ...

A decade after Big Pharma banned branded pens and swag for doctors under its own ethics code, telehealth, diagnostics and imaging startups are now using celebrity stories to sell prescription drugs ...

Analogue computers that rapidly solve a key type of equation used in training artificial intelligence models could offer a potential solution to the growing energy consumption in data centres caused ...

If your patients are taking GLP-1s, you’ve explained the common side effects, such as gastrointestinal (GI) issues and muscle-loss implications. However, GLP-1 receptor agonists, often prescribed for ...

Discount wars, tariff concerns and growing access to weight-loss drugs have made for a tough year for restaurant chains. But a BTIG analyst on Wednesday said investors might be treating some chains — ...